Ansari, Sam
Baumer, Karine
Boué, Stéphanie
Dijon, Sophie
Dulize, Remi
Ekroos, Kim
Elamin, Ashraf
Foong, Clement
Guedj, Emmanuel
Hoeng, Julia
Ivanov, Nikolai V.
Krishnan, Subash
Leroy, Patrice
Martin, Florian
Merg, Celine
Peck, Michael J.
Peitsch, Manuel C.
Phillips, Blaine
Schlage, Walter K.
Schneider, Thomas
Talikka, Marja
Titz, Bjoern
Vanscheeuwijck, Patrick
Veljkovic, Emilija
Vihervaara, Terhi
Vuillaume, Gregory
Woon, Ching Qing
Article History
Received: 29 December 2014
Accepted: 19 November 2015
First Online: 5 January 2016
Competing interests
: The authors are employed by Philip Morris International R&D. For this prototype MRTP there are no defined or publicly made statements about market launches, filings, or pending applications in place. In accordance with the latest presentation to shareholders by PMI’s CEO on May 6, 2015 (see ExternalRef removed, slide 29), this product category is currently in the phase of clinical trials. Authors have no other conflict of interest to declare.